Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 281

    1.

    Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice.

    How OJ, Aasum E, Severson DL, Chan WY, Essop MF, Larsen TS.

    Diabetes. 2006 Feb;55(2):466-73.PMID: 16443782 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Rosiglitazone treatment improves cardiac efficiency in hearts from diabetic mice.

    How OJ, Larsen TS, Hafstad AD, Khalid A, Myhre ES, Murray AJ, Boardman NT, Cole M, Clarke K, Severson DL, Aasum E.

    Arch Physiol Biochem. 2007 Oct-Dec;113(4-5):211-20.PMID: 18158644 [PubMed - indexed for MEDLINE]Related articles

    3.

    Increased O2 cost of basal metabolism and excitation-contraction coupling in hearts from type 2 diabetic mice.

    Boardman N, Hafstad AD, Larsen TS, Severson DL, Aasum E.

    Am J Physiol Heart Circ Physiol. 2009 May;296(5):H1373-9. Epub 2009 Mar 13.PMID: 19286944 [PubMed - indexed for MEDLINE]Related articles

    4.

    Influence of substrate supply on cardiac efficiency, as measured by pressure-volume analysis in ex vivo mouse hearts.

    How OJ, Aasum E, Kunnathu S, Severson DL, Myhre ES, Larsen TS.

    Am J Physiol Heart Circ Physiol. 2005 Jun;288(6):H2979-85. Epub 2005 Mar 11.PMID: 15764683 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Glucose and insulin improve cardiac efficiency and postischemic functional recovery in perfused hearts from type 2 diabetic (db/db) mice.

    Hafstad AD, Khalid AM, How OJ, Larsen TS, Aasum E.

    Am J Physiol Endocrinol Metab. 2007 May;292(5):E1288-94. Epub 2007 Jan 9.PMID: 17213470 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice.

    Belke DD, Larsen TS, Gibbs EM, Severson DL.

    Am J Physiol Endocrinol Metab. 2000 Nov;279(5):E1104-13.PMID: 11052966 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Type 1 diabetic akita mouse hearts are insulin sensitive but manifest structurally abnormal mitochondria that remain coupled despite increased uncoupling protein 3.

    Bugger H, Boudina S, Hu XX, Tuinei J, Zaha VG, Theobald HA, Yun UJ, McQueen AP, Wayment B, Litwin SE, Abel ED.

    Diabetes. 2008 Nov;57(11):2924-32. Epub 2008 Aug 4.PMID: 18678617 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Left ventricular oxygen utilization efficiency is impaired in chronic streptozotocin-diabetic sheep.

    Ramanathan T, Shirota K, Morita S, Nishimura T, Huang Y, Zheng X, Hunyor S.

    Cardiovasc Res. 2002 Sep;55(4):749-56.PMID: 12176124 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity.

    Buchanan J, Mazumder PK, Hu P, Chakrabarti G, Roberts MW, Yun UJ, Cooksey RC, Litwin SE, Abel ED.

    Endocrinology. 2005 Dec;146(12):5341-9. Epub 2005 Sep 1.PMID: 16141388 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Effects of propionyl-carnitine on mitochondrial respiration and post-ischaemic cardiac function in the ischaemic underperfused diabetic rat heart.

    Broderick TL, Paulson DJ, Gillis M.

    Drugs R D. 2004;5(4):191-201.PMID: 15230624 [PubMed - indexed for MEDLINE]Related articles

    11.

    Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice.

    Aasum E, Hafstad AD, Severson DL, Larsen TS.

    Diabetes. 2003 Feb;52(2):434-41.PMID: 12540618 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Effect of BM 17.0744, a PPARalpha ligand, on the metabolism of perfused hearts from control and diabetic mice.

    Aasum E, Cooper M, Severson DL, Larsen TS.

    Can J Physiol Pharmacol. 2005 Feb;83(2):183-90.PMID: 15791292 [PubMed - indexed for MEDLINE]Related articles

    13.

    Fatty acid metabolism is enhanced in type 2 diabetic hearts.

    Carley AN, Severson DL.

    Biochim Biophys Acta. 2005 May 15;1734(2):112-26. Epub 2005 Apr 9. Review.PMID: 15904868 [PubMed - indexed for MEDLINE]Related articles

    14.

    What are the biochemical mechanisms responsible for enhanced fatty acid utilization by perfused hearts from type 2 diabetic db/db mice?

    Carley AN, Severson DL.

    Cardiovasc Drugs Ther. 2008 Apr;22(2):83-9. Review.PMID: 18247111 [PubMed - indexed for MEDLINE]Related articles

    15.

    Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins.

    Boudina S, Sena S, Theobald H, Sheng X, Wright JJ, Hu XX, Aziz S, Johnson JI, Bugger H, Zaha VG, Abel ED.

    Diabetes. 2007 Oct;56(10):2457-66. Epub 2007 Jul 10.PMID: 17623815 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Comparative investigation of the left ventricular pressure-volume relationship in rat models of type 1 and type 2 diabetes mellitus.

    Radovits T, Korkmaz S, Loganathan S, Barnucz E, Bömicke T, Arif R, Karck M, Szabó G.

    Am J Physiol Heart Circ Physiol. 2009 Jul;297(1):H125-33. Epub 2009 May 8.PMID: 19429826 [PubMed - indexed for MEDLINE]Related articles

    17.

    Myocardial efficiency in stunned myocardium. Comparison of Ca(2+)-sensitization and PDE III-inhibition on energy consumption.

    Sunderdiek U, Korbmacher B, Gams E, Schipke JD.

    Eur J Cardiothorac Surg. 2000 Jul;18(1):83-9.PMID: 10869945 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Chylomicron and palmitate metabolism by perfused hearts from diabetic mice.

    Neitzel AS, Carley AN, Severson DL.

    Am J Physiol Endocrinol Metab. 2003 Feb;284(2):E357-65. Epub 2002 Oct 22.PMID: 12397026 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Preserved myocardial energetics in acute ischemic left ventricular failure -- studies in an experimental pig model.

    Nordhaug D, Steensrud T, Korvald C, Aghajani E, Myrmel T.

    Eur J Cardiothorac Surg. 2002 Jul;22(1):135-42.PMID: 12103387 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Treatment of type 2 diabetic db/db mice with a novel PPARgamma agonist improves cardiac metabolism but not contractile function.

    Carley AN, Semeniuk LM, Shimoni Y, Aasum E, Larsen TS, Berger JP, Severson DL.

    Am J Physiol Endocrinol Metab. 2004 Mar;286(3):E449-55. Epub 2003 Nov 4.PMID: 14600074 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data